£27,200/Yr
TheÊÊBiochemistry with Medical Biochemistry course at University of Bristol offers a breadth of topics, allowing you to choose your specialism whilst developing your knowledge and research skills.
In your first two years you will supplement your study of biochemistry with units relevant to medicine, such as pharmacology, physiology and molecular pathology. Your third year focuses on medically relevant aspects of biochemistry, such as those relating to cancer, cardiovascular disease and drug design.
Your final-year research project will involve collaboration with internationally renowned scientists on pioneering work. Our students recently collaborated on the development of a technique for the manufacture of red blood cells from human stem cells, and on the molecular modification of an antibiotic, increasing the range of infections it can treat.
We prepare you for your future career with subject-specific employability and enterprise sessions and the chance to gain additional research experience in a summer studentship.
Important Dates
Event | Application Date |
---|---|
UCAS Application Deadline For 2024 Intake | |
Tuition Fees
Year | 1st Year Fees |
---|---|
Tuition Fees | £27200 (GBP 27200) |
Scholarship Grants & Financial Aids
Name | Scholarship Per Student | Level of Study | Type | |
---|---|---|---|---|
Aviva Scholarships | Scholarship per studentVariable Amount | Level Of StudyBachelor | TypeMerit-Based | |
Bristol's Vice Chancellor's Scholarship | Scholarship per student£ 3,870/Yr$3,870 | Level Of StudyBachelor | TypeAwards | |
Collegedunia $150 Scholarship Program | Scholarship per student£ 150/Yr$150 | Level Of StudyBachelor | TypeMerit-Based | |
Deutschland Stipendium Program | Scholarship per student£ 4,363/Yr$4,363 | Level Of StudyBachelor | TypeCollege-Specific | |
Debesh Kamal Scholarship | Scholarship per student£ 1,385/Yr$1,385 | Level Of StudyBachelor | TypeMerit-Based | |
Forktip Women’s- Innovation Scholarship | Scholarship per studentVariable Amount | Level Of StudyBachelor | TypeCollege-Specific |
Comments